BARRIERS AND FACILITATORS TO UNDERGOING HEPATITIS C VIRUS (HCV) TESTING THROUGH DRUG TREATMENT PROGRAMS
Salvato in:
STRAUSS, S.M., ET AL., BARRIERS AND FACILITATORS TO UNDERGOING HEPATITIS C VIRUS (HCV) TESTING THROUGH DRUG TREATMENT PROGRAMS. JOURNAL OF DRUG ISSUES, Vol. 38, no. 4 (2008), p. 1161-1186.
Ref.
159368
Localizzazione:
SIIS R.993 Archivo
Palabras clave:
Detección, Drogas ilegales, Drogodependencias, Hepatitis, Programas de desintoxicación, Tests, Utilización de servicios
Detección, Drogas ilegales, Drogodependencias, Hepatitis, Programas de desintoxicación, Tests, Utilización de servicios
Documenti analoghi: BARRIERS AND FACILITATORS TO UNDERGOING HEPATITIS C VIRUS (HCV) TESTING THROUGH DRUG TREATMENT PROGRAMS
- Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs
- HCV (HEPATITIS C VIRUS) PRE TEST AND POST TEST COUNSELING SERVICES AT DRUG TREATMEN PROGRAMS: MISSED OPPORTUNITIES FOR PRIMARY PREVENTION
- Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users
- Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial
- ACCEPTABILITY OF HEPATITIS C VIRUS TESTING METHODS AMONG INJECTING DRUG USERS
- Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection